Why Solesence, Inc.’s (SLSN) Stock Is Down 6.07%
As of Friday, August 21, Solesence, Inc.’s SLSN share price has dipped by 6.07%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Commentary & Analysis
Why Solesence, Inc.’s (SLSN) Stock Is Down 6.11%
As of Friday, August 21, Solesence, Inc.’s SLSN share price has dipped by 6.11%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Solesence, Inc.’s (SLSN) Stock Is Up 11.19%
As of Wednesday, August 19, Solesence, Inc.’s SLSN share price has surged by 11.19%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Solesence, Inc.’s (SLSN) Stock Is Up 8.86%
As of Wednesday, August 19, Solesence, Inc.’s SLSN share price has surged by 8.86%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Solesence, Inc.’s (SLSN) Stock Is Down 9.11%
As of Tuesday, August 18, Solesence, Inc.’s SLSN share price has dipped by 9.11%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | SLSN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $67.1 | $3,956.7 | 17% |
|
| Shares Out (Mil) | 70.6 | 92.2 | 55% |
|
| Institutional Ownership | 5.8% | 82.7% | 5% |
|
| Float (Mil) | 18.3 | 117.6 | 27% |
|
| Beta | na | 0.78 | na |
|
| Avg Daily Volume (000s) | 25 | 137 | 22% |
|
| Price Change (52-week) |
(72.9%) | 85.4% | 8% |
|
| Growth | SLSN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 29.4% | 4.0% | 89% |
|
| Net Income (5yr) | 12.5% | (0.2%) | 59% |
|
| EPS (5yr) | (5.1%) | 1.5% | 25 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 14.9% | (15.3%) | 72% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | SLSN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $55 | $4,298 | 21% |
|
| Net Income (TTM) (Mil) | ($3) | $58 | 35% |
|
| EPS (TTM) | ($0.041) | $0.300 | 38% |
|
| Operating Cash Flow (TTM) (Mil) | $1 | $446 | 33% |
|
| Net Cash Flow (TTM) (Mil) | ($3) | $4 | 36% |
|
| Long-Term Debt (Q1) (Mil) | $7 | $1,795 | 26% |
|
| Enterprise Value (Q1) (Mil) | $88 | $5,576 | 21% |
|
| Valuation | SLSN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.00 | 1.60 | 78% |
|
| P/E | na | 24.6 | na |
|
| Dividend Yield | 0.0% | 1.1% | 0% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | SLSN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 25.0% | 27.5% | 28% |
|
| Net Margin | (5.3%) | 3.0% | 25% |
|
| ROA | (5.5%) | 1.5% | 29% |
|
| ROE | (18.6%) | 3.9% | 24% |
|
| Liabilities to Assets | 71.7% | 54.0% | 67% |
|
| F-Score | 3 | 5 | 18% |
|
Solesence, Inc. did not pass any screens on 8/21/2026.
